AJP - Renal Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (October 30, 2001). doi:10.1152/ajprenal.00026.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/F741    most recent
00026.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehrke, I.
Right arrow Articles by Wagner, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lehrke, I.
Right arrow Articles by Wagner, J.

Articles in PresS, published online ahead of print October 30, 2001
Am J Physiol Renal Physiol, 10.1152/ajprenal.00026.2001
Submitted on February 2, 2001
Accepted on October 12, 2001

RETINOID RECEPTOR-SPECIFIC AGONISTS ALLEVIATE EXPERIMENTAL GLOMERULONEPHRITIS

Ingo Lehrke1, Matthias Schaier1, Kerstin Schade1, Christian Morath1, Ruediger Waldherr1, Eberhard Ritz1, and Juergen Wagner1*

1 Nephrology, University of Heidelberg, Heidelberg, Germany

* To whom correspondence should be addressed. E-mail: juergen.wagner{at}urz.uni-heidelberg.de.

Retinoids are potent anti-proliferative and anti-inflammatory compounds. We previously demonstrated that the natural pan-agonists all-trans retinoic acid (RA) and 13-cis RA efficiently preserve renal structure and function in rat mesangioproliferative glomerulonephritis. We now examined the effects of synthetic retinoid-receptor-specific agonists i) to identify common and receptor subtype specific pathways in this model and ii) to characterize effects of retinoids on the renal endothelin (ET) system. Vehicle-injected control rats were compared to rats treated with daily subcutaneous injections of agonists specific for retinoid-A-receptor (Ro137410) and retinoid-X-receptor (Ro257386), and the complex anti-activator protein-1 active retinoid BMS453 seven days after induction of anti-Thy1.1-nephritis (n=7-9 per group). The different retinoids lowered with comparable efficacy glomerular ET-1, ETA and ETB receptor gene expression in control and nephritic rats. Reduction of glomerular c-Fos and GATA-2 mRNA expression levels suggests down-regulation of transactivating factors required for endothelin expression. The different retinoids were similar in their action on glomerular capillary occlusion score, number of total glomerular cells and glomerular infiltrating macrophage count. They did, however, differ in their ability to normalize blood pressure (Ro257386>BMS453>Arotinoid), albuminuria (BMS453>Ro257386>Arotinoid) and creatinine clearance (Arotinoid>BMS453> Ro257386). No signs of toxicity were observed. We conclude that all retinoid agonists with different subtype specificity are highly efficient in reducing renal damage and proliferation of mesangial cells. Both retinoid X and A receptor-specific pathways are apparently involved in the anti-proliferative, anti-inflammatory and anti-endothelin action. Further studies are indicated to define the potential use of retinoid agonists in inflammatory renal disease.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Okamura, Y. Takano, Y. Saito, J. Yao, and M. Kitamura
Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3006 - 3012.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T.-C. Lu, Z. Wang, X. Feng, P. Chuang, W. Fang, Y. Chen, S. Neves, A. Maayan, H. Xiong, Y. Liu, et al.
Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected Podocytes
Mol. Cell. Biol., September 15, 2008; 28(18): 5785 - 5794.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. C. He, T.-C. Lu, M. Fleet, M. Sunamoto, M. Husain, W. Fang, S. Neves, Y. Chen, S. Shankland, R. Iyengar, et al.
Retinoic Acid Inhibits HIV-1-Induced Podocyte Proliferation through the cAMP Pathway
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 93 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Yamauchi, A. Ishibashi, K. Shikata, N. Tokuhara, K.-i. Seino, S. Kobayashi, and M. Nagai
Effect of E6060 [4-{5-[7-Fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic Acid], a Novel Subtype-Selective Retinoid, on Lupus-Like Nephritis in Female (NZBxNZW)F1 Mice
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Liebler, B. Uberschar, H. Kubert, S. Brems, A. Schnitger, M. Tsukada, C. C. Zouboulis, E. Ritz, and J. Wagner
The renal retinoid system: time-dependent activation in experimental glomerulonephritis
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F458 - F465.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.